Compare AXON & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXON | CNC |
|---|---|---|
| Founded | 1993 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6B | 32.9B |
| IPO Year | 2001 | 2001 |
| Metric | AXON | CNC |
|---|---|---|
| Price | $379.11 | $73.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 21 |
| Target Price | ★ $680.37 | $74.50 |
| AVG Volume (30 Days) | 904.8K | ★ 4.8M |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.41 | ★ 5.15 |
| Revenue | $2,779,536,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $33.35 | $13.46 |
| Revenue Next Year | $29.47 | N/A |
| P/E Ratio | $176.01 | ★ $14.76 |
| Revenue Growth | ★ 33.47 | 19.44 |
| 52 Week Low | $339.01 | $31.63 |
| 52 Week High | $665.07 | $77.05 |
| Indicator | AXON | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 48.47 | 68.27 |
| Support Level | $402.98 | $62.98 |
| Resistance Level | $438.97 | N/A |
| Average True Range (ATR) | 17.41 | 3.18 |
| MACD | 4.74 | 0.19 |
| Stochastic Oscillator | 75.18 | 91.48 |
Axon was founded in 1993, but its roots trace back to the invention of the Taser in 1974 by Jack Cover. Over the decades, Axon has expanded its product suite to include police body-worn cameras, a cloud-based evidence repository, AI-driven report-drafting software, drones and counter-drone sensors, and 911 dispatching software. The firm sells its products to end markets such as local and federal law enforcement, enterprise, corrections, and healthcare. It derives around four-fifths of its revenue from the US, with the remainder from international countries.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.